Changes in the cannabinoids receptors in rats following treatment with antidepressants

  title={Changes in the cannabinoids receptors in rats following treatment with antidepressants},
  author={I. Smaga and M. Zaniewska and D. Gawliński and A. Faron-G{\'o}recka and P. Szafranski and M. Cegła and M. Filip},
Graphical abstract Figure. No caption available. HighlightsAntidepressant treatment increases cortical and hippocampal CB1 receptor density.Imipramine and escitalopram reduce striatal CB1 receptor expression.Escitalopram and tianeptine increase hippocampal CB1 receptor expression.Repeated exposure to antidepressants alters expression of brain CB2 receptors. &NA; The endocannabinoid (eCB) system plays a significant role in the pathophysiology of depression. The potential participation of this… Expand
Adaptive mechanisms following antidepressant drugs: Focus on serotonin 5-HT2A receptors.
The present result indicate different sensitivity of brain 5-HT2A receptors to antidepressant drugs depending on schedule of drug administration and rat brain regions. Expand
Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice
Results of the present study showed that activation and inhibition of CB1 receptors as well as inhibition ofCB2 receptors may increase the antidepressant activity of tianeptine, whereas only inhibition of CPC1 and CB2 receptors has a potential to augment the antidepressants activity of agomelatine. Expand
Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice
Both activation and inhibition of the CB2 receptor function have a potential to strengthen the antidepressant activity of drugs targeting the monoaminergic system. Expand
Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
Results suggest that BCP may be effective in treating depression and stress related mental illnesses and improve chronic stress related behavioral and biochemical changes. Expand
Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling
  • S. Xue, F. Xue, +6 authors Z. Peng
  • Medicine, Chemistry
  • Pharmacology Biochemistry and Behavior
  • 2019
Interestingly, it is found that only high-frequency rTMS ameliorated depressive-like behaviors and normalized the expression of hippocampal synaptic proteins in CUS-treated rats; this effect was eliminated by knockdown of DAGLα or CB1R. Expand
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Current evidence suggests that the components of the ECS may become promising biomarkers in psychiatry to improve, at least in part, the diagnosis and pharmacological treatment of psychiatric disorders. Expand
Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder
It is reported for the first time a significant association of human circulating eCB and antidepressant effect of rTMS, which may indicate that direct stimulation of targeted brain areas can rapidly alleviate depressive complaints via activation of the eCB system. Expand
Maternal High-Fat Diet Modulates Cnr1 Gene Expression in Male Rat Offspring
In recent years, strong evidence has emerged that exposure to a maternal high-fat diet (HFD) provokes changes in the structure, function, and development of the offspring’s brain and may induceExpand
Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial
  • Chung-Chieh Hung, Chien-Hung Lee, Albert Min-Shan Ko, H. Lane, Chi‐Pin Lee, Ying-Chin Ko
  • Medicine
  • Epidemiology and Psychiatric Sciences
  • 2020
Prescribing a fixed dose of moclobemide and escitalopram to BUD patients over 8 weeks demonstrated treatment benefits to betel-quid chewing cessation (BQ-CC), which provides preliminary evidence and requires replication in larger trials. Expand
Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients
Cannabis consumption may produce a protective effect against liver steatosis in psychosis, probably through the modulation of antipsychotic-induced weight gain. Expand


Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
The data suggest that the endocannabinoid system in cortical and subcortical structures is differentially altered in an animal model of depression and that the effects of CUS on CB1 receptor binding site density are attenuated by antidepressant treatment while those on endOCannabinoid content are not. Expand
Changes in the Brain Endocannabinoid System in Rat Models of Depression
Dysregulation in the eCB system is implicated in the pathogenesis of depression, although neurochemical changes were linked to the particular brain structure and the factor inducing depression (surgical removal of the olfactory bulbs vs. genetic modulation). Expand
Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus
The antidepressant-induced increase in the number of GLUR1- and GluR2/3-containing AMPARs at the synapses may indicate an enhanced AMPAR-mediated synaptic transmission which could help to counteract the alterations in neuronal connectivity which appear to underlie the pathophysiology of mood disorders. Expand
Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex
It is demonstrated that CB1R agonists possess antidepressant-like properties and modulate 5-HT neuronal activity via the mPFCv and in vivo electrophysiology shows that low doses of WIN55,212-2 dose dependently enhanced dorsal raphe nucleus 5- HT neuronal activity through aCB1R-dependent mechanism. Expand
Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment
No changes in expression and density of both 5-HT2AR and mGlu2/3R are demonstrated in the postmortem prefrontal cortex of subjects with major depressive disorder under basal conditions, which suggests that 5- HT2AR down-regulation may be a mechanism for antidepressant effect. Expand
Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
The functional expression of CB2-Rs in brain that may provide novel targets for the effects of cannabinoids in depression and substance abuse disorders beyond neuro-immunocannabinoid activity is demonstrated. Expand
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides.
The findings suggest that alcohol dependence is associated with the downregulation of the CB1 receptors, while suicide is linked to the upregulation of these receptors in the ventral striatum. Expand
Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT2A and dopamine D2 receptors in rat prefrontal cortex
Positive experimental evidence is presented that Sprague-Dawley rats treated with a non-selective cannabinoid receptor agonist showed enhanced co-immunoprecipitation of 5-HT2A and D2 receptors and enhanced membrane-associated expression of D2 and 5- HT2A receptors in prefrontal cortex (PFCx), suggesting a cannabinoid-induced upregulation of5-HT 2A receptors. Expand
Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
The endocannabinoid system appears to play a significant role in the mechanism of action of clinically effective and potential antidepressants and may serve as a target for drug design and discovery. Expand
Activation of endocannabinoid transmission induces antidepressant-like effects in rats.
Recent reports indicate that endocannabinoid (eCB) system may be involved in depression and in the antidepressant-like activity demonstrated in experimental models. The present study examined theExpand